Chris Claxton

Chris Claxton is a seasoned professional with extensive experience in investor relations and marketing, currently serving as VP of Investor Relations & Marketing at Owlstone Medical since July 2018. Previously, Chris held key roles such as Head of Investor Relations at Horizon Discovery and VP of Investor Relations & Corporate Communications, where responsibilities included crafting investment messages and monitoring investor community feedback. Earlier experience includes positions such as VP Marketing, Market Segment Manager at SAFC, and Director of Marketing at ArcticDX. Chris's career also includes significant contributions to Luminex Corporation in strategic marketing and management roles, along with consulting and research positions in the early career stages. Chris holds an MBA in Strategy and Marketing from the Rotman School of Management and multiple degrees in Clinical Biochemistry and Molecular Genetics from the University of Toronto and the University of Waterloo.